ENTRY       D12149                      Drug
NAME        Plasminogen;
            Glu-plasminogen;
            Plasminogen, human-tvmh;
            Ryplazim (TN)
EFFICACY    Enzyme replacement (plasminogen)
  DISEASE   Plasminogen deficiency type 1 [DS:H01206]
TARGET      PLG [HSA:5340] [KO:K01315]
  PATHWAY   hsa04080(5340)  Neuroactive ligand-receptor interaction
            hsa04610(5340)  Complement and coagulation cascades
BRITE       Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Serine peptidases
                PLG
                 D12149  Plasminogen
            New drug approvals in the USA [br08319.html]
             Cellular and gene therapy products
              D12149
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12149
DBLINKS     CAS: 9001-91-6
///
